rs11668950

This is a downstream gene variant variant in the IFI30 gene.

GWAS Catalog Trait Associations (2)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

health study participation

Allele A
OR 0.01
p 3.0e-8
N 371,428
Large GWAS
European

serum alanine aminotransferase amount

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.02
p 6.0e-13
N 584,062
Major Consortium StudyLarge GWAS
multi-ancestry

Research that mentions this SNP (1)

A polymorphism of the interferon-gamma-inducible protein 30 gene is associated with hyperglycemia in severely obese individuals
AssociationN=1,283Turcot V. et al.(2012)· Human Genetics

A two-stage case-control study in 1,283 severely obese individuals identified a significant association between the IFI30 gene SNP rs11554159 (p.R76Q) and hyperglycemia/type 2 diabetes risk. Heterozygous GA individuals showed reduced risk compared to GG homozygotes (OR=0.67, P=0.0009). The protective effect was not explained by differences in IFI30 mRNA expression levels in visceral adipose tissue, suggesting a functional effect of the variant rather than an expression effect.

Traits studied:Cardiovascular disease risk factorsDyslipidemiaFasting plasma glucoseHyperglycemiaHypertensionMetabolic syndromeType 2 diabetes

About IFI30

The protein encoded by this gene is a lysosomal thiol reductase that at low pH can reduce protein disulfide bonds. The enzyme is expressed constitutively in antigen-presenting cells and induced by gamma-interferon in other cell types. This enzyme has an important role in MHC class II-restricted antigen processing. [provided by RefSeq, Jul 2008]

View all IFI30 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…